New hope for malaria patients with G6PD deficiency: safer drug regimens under study
NCT ID NCT07468513
First seen Mar 24, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study looks at how safe and effective primaquine is for treating vivax malaria in people with intermediate or deficient G6PD enzyme levels. About 100 adults will receive either a daily high dose for a week or a weekly dose, depending on their G6PD activity. The goal is to find a treatment that works without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIVAX MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arba Minch General Hospital
NOT_YET_RECRUITINGArba Minch, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dr Marcus Lacerda
RECRUITINGManaus, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dr Moses Laman and Dr Brioni Moore
RECRUITINGAlexishafen, Madang Province, Papua New Guinea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Papua New Guinea Institute of Medical Research
RECRUITINGPort Moresby, Magang, Papua New Guinea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.